TribAway
The Endovenous Phlebectomy Solution
About the treatment of varicose veins
We did learned since the last 15 years :
We also learned since the first publication in 2005 about the ASVAL Method by Drs Pittaluga & Chastanet that the treatment of the varicose tributaries is efficient even performed alone. In addition, the last studies have shown that even at mid and long term isolated phlebectomy sparing the saphenous vein according to the ASVAL principles can be as efficient as saphenous ablations.
Therefore the treatment of the so-called “Varicose Reservoir” is likely the key element for a proper treatment of the varicose disease, since it is indicated alone at early stage of the disease or concomitantly to saphenous ablation at more evolved stages.
Even if an efficient and minimally invasive treatment of varicose reservoir can be done by the micro-surgical technique developed at the Riviera Vein Institute, an evolution towards an endovenous treatment of tributaries seems to be the next innovation.
The TribAway, an innovative treatment for varicose tributaries
Drs Chastanet and Pittaluga faced several issues for for treating the varicose tributaries by current endovenous technologies because of a lack of a transportation method for navigating in tortuous and uneven vein architectures, such as :
Finally Drs Chastanet and Pittaluga came with a new concept of directional carrier that will optimize in-vein progression enabling and delivering an energy all along the tortuous varicose tributaries for endovenous ablation: “The TribAway project”.
The TribAway is a proprietary and innovative treatment for varicose tributaries, alone or in combination to saphenous ablation. The device has gone through the Research, Design and IP phases, and we are now entering development cycles.
Keep being posted !
Video
